http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories
-
10x Genomics to Report First Quarter 2025 Financial Results on May 8, 2025
-
10x Genomics (TXG) Secures Injunction Against Parse Biosciences' Planned ATAC Products
-
10x Genomics Secures Injunction Against Parse Biosciences' Planned ATAC Products
-
10x Genomics Unveils Innovation Roadmap at AGBT General Meeting, Advancing Leadership in Large-Scale Single Cell and Spatial Analysis
-
10x Genomics to Participate in the 45th Annual TD Cowen Health Care Conference
-
10x Genomics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Outlook for 2025
-
Chan Zuckerberg Initiative Launches Billion Cells Project with 10x Genomics and Ultima Genomics to Advance AI in Biology
-
10x Genomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 12, 2025
-
10x Genomics (TXG) Announces Preliminary Select Fourth Quarter and Full Year 2024 Results
-
10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2024 Results
-
10x Genomics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
U.S. District Court Awards 10x Genomics (TXG) Permanent Injunction in Patent Infringement Lawsuit Against Bruker Corporation's GeoMx Products
-
U.S. District Court Awards 10x Genomics Permanent Injunction in Patent Infringement Lawsuit Against Bruker Corporation's GeoMx Products
-
10x Genomics to Present at the Wolfe Research 2024 Healthcare Conference
-
TechBio Startup Cure51 Selects 10x Genomics Visium HD for New Drug Discovery Initiative
-
10x Genomics Reports Third Quarter 2024 Financial Results
-
10x Genomics Delivers 'Single Cell for a Single Cent' with New Chromium Launches
-
10x Genomics (TXG) sees revenue of approximately $151.7 million for the third quarter
-
10x Genomics Announces Preliminary Select Third Quarter 2024 Results
-
10x Genomics Announces Mega-Scale Single Cell Analysis for One Cent Per Cell at Human Cell Atlas General Meeting
-
Lausanne Researchers Combine 10x Genomics' Chromium and Xenium for Novel Insights into Resistance and Potential Therapeutics for Brain Cancer
-
10x Genomics Unveils Chromium Xo: A Low-Cost Instrument to Expand Access to High-Performance Single Cell Research
-
10x Genomics to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
-
10x Genomics (TXG) Announces Leadership Changes
-
10x Genomics Announces Senior Leadership Changes
-
10x Genomics Reports Second Quarter 2024 Financial Results
-
10x Genomics Technology Supports TenK10K Project Led by Garvan Institute of Medical Research to Help Transform the Treatment of Complex Diseases
-
10x Genomics to Report Second Quarter 2024 Financial Results on August 8, 2024
-
New Insights Into Cleft Palate Unlocked With 10x Genomics' Single Cell and Spatial Technologies
-
10x Genomics (TXG) Begins Commercial Shipments of Xenium Prime 5K Pan-Tissue and Pathways Panel
-
10x Genomics Begins Commercial Shipments of Xenium Prime 5K Pan-Tissue and Pathways Panel
-
10x Genomics (TXG) Launches 5,000-Plex Gene Panel for Xenium
-
10x Genomics Launches 5,000-Plex Gene Panel for Xenium
-
10x Genomics to Present at the BofA Securities 2024 Healthcare Conference
-
10x Genomics Reports First Quarter 2024 Financial Results
-
10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024
-
10x Genomics (TXG) Commercially Launches Visium HD Spatial Gene Expression Assay
-
10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay
-
10x Genomics (TXG) Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel
-
10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel
-
10x Genomics (TXG) Begins Commercial Shipments of Chromium GEM-X Products
-
10x Genomics Begins Commercial Shipments of Chromium GEM-X Products
-
10x Genomics to Present at the 44th Annual TD Cowen Health Care Conference
-
10x Genomics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Outlook for 2024
-
10x Genomics Expands Leadership in Single Cell Analysis with Launch of GEM-X Technology
-
10x Genomics to Showcase New Cutting-Edge Technologies and Highlight Innovation Roadmap at 2024 AGBT General Meeting
-
10x Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024
-
10x Genomics (TXG) Announces Preliminary Fourth Quarter and Full Year 2023 Results
-
10x Genomics Announces Preliminary Fourth Quarter and Full Year 2023 Results
-
10x Genomics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

